Combination drug therapy for the treatment of status epilepticus

References

• Hocker S, Tatum WO, LaRoche S, Freeman WD. Refractory and super-refractory status epilepticus – an update. Curr Neurol Neurosci Rep 2014;14(6):452
   PubMed Web of Science ®Google Scholar
• Csilla G, Vera J, Reka H, et al. Status epilepticus and its treatment – update 2013. Ideggyogy Sz 2013;66(11-12):372-82
   PubMedGoogle Scholar
• Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 2011;10(10):922-30
   PubMed Web of Science ®Google Scholar
• Chen JWY, Wasterlain CG. Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006;5(3):246-56
   PubMed Web of Science ®Google Scholar
• Wasterlain CG, Baldwin R, Naylor DE, et al. Rational polytherapy in the treatment of acute seizures and status epilepticus. Epilepsia 2011;52(Suppl 8)):70-1
   PubMedGoogle Scholar
• Miller KL, Liebowitz RS, Newby LK. Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches. Am Heart J 2004;147(3):401-11
   PubMedGoogle Scholar
• Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 1998;814(1-2):179-85
   PubMed Web of Science ®Google Scholar
• Mazarati AM, Wasterlain CG. N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett 1999;265(3):187-90
   PubMed Web of Science ®Google Scholar
• Matagne A BE, Coupez R, Patsalos PN, Klitgaard H. Levetiracetam enhances markedly the seizure suppression of other antiepileptic drugs in audiogenic susceptible mice. Epilepsia 2001;42(Suppl 7):82
   Google Scholar
• Klitgaard H MA. Levetiracetam enhances markedly the seizure suppression of other antiepileptic drugs in amygdala-kindled rats. Epilepsia 2002;43(Suppl 7):219
   PubMedGoogle Scholar
• Kirmani BF, Robinson DM, Kikam A, et al. Selection of antiepileptic drugs in older people. Curr Treat Options Neurol 2014;16(6):295
   PubMedGoogle Scholar
• Rice AC, DeLorenzo RJ. N-methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam. Neuroscience 1999;93(1):117-23
   PubMedGoogle Scholar
• Vermoesen K, Smolders I, Massie A, et al. The control of kainic acid-induced status epilepticus. Epilepsy Res 2010;90(1-2):164-6
   PubMedGoogle Scholar
• Francois J, Koning E, Ferrandon A, Nehlig A. The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res 2006;72(2-3):147-63
   PubMedGoogle Scholar
• Synowiec AS, Singh DS, Yenugadhati V, et al. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res 2013;105(1-2):183-8
   PubMed Web of Science ®Google Scholar
• Uges JW, van Huizen MD, Engelsman J, et al. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus. Epilepsia 2009;50(3):415-21
   PubMed Web of Science ®Google Scholar
• Gallentine WB, Hunnicutt AS, Husain AM. Levetiracetam in children with refractory status epilepticus. Epilepsy Behav 2009;14(1):215-18
   PubMed Web of Science ®Google Scholar
• Su TF, Xu SQ, Chen L. Efficacy of levetiracetam combined with short-term clonazepam in treatment of electrical status epilepticus during sleep in children with benign childhood epilepsy with centrotemporal spikes. Zhongguo Dang Dai Er Ke Za Zhi 2014;16(8):829-33
   PubMedGoogle Scholar
• Rossetti AO, Reichhart MD, Schaller M-D, et al. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia 2004;45(7):757-63
   PubMed Web of Science ®Google Scholar
• Cook AM, Castle A, Green A, et al. Practice variations in the management of status epilepticus. Neurocrit Care 2012;17(1):24-30
   PubMedGoogle Scholar
• Abend NS, Dlugos DJ, Clancy RR. A review of long-term EEG monitoring in critically ill children with hypoxic-ischemic encephalopathy, congenital heart disease, ECMO, and stroke. J Clin Neurophysiol 2013;30(2):134-42
   PubMedGoogle Scholar
• Arik Y, Leijten FS, Seute T, et al. Prognosis and therapy of tumor-related versus non-tumor-related status epilepticus: a systematic review and meta-analysis. BMC Neurol 2014;14:152
   PubMed Web of Science ®Google Scholar
• Fernandez-Torre JL, Kaplan PW. Subacute encephalopathy with seizures in alcoholics (SESA syndrome) revisited. Seizure 2014;23(5):393-6
   PubMedGoogle Scholar
• Kaplan PW, Rossetti AO, Kaplan EH, Wieser HG. Proposition: limbic encephalitis may represent limbic status epilepticus. A review of clinical and EEG characteristics. Epilepsy Behav 2012;24(1):1-6
   PubMedGoogle Scholar
• Kramer AH. Viral encephalitis in the ICU. Crit Care Clin 2013;29(3):621-49
   PubMedGoogle Scholar
• Menon R, Radhakrishnan A, Radhakrishnan K. Status epilepticus. J Assoc Physicians India 2013;61(8 Suppl):58-63
   PubMedGoogle Scholar
• Nair PP, Kalita J, Misra UK. Status epilepticus: why, what, and how. J Postgrad Med 2011;57(3):242-52
   PubMedGoogle Scholar
• Sutter R, Kaplan PW. Electroencephalographic criteria for nonconvulsive status epilepticus: synopsis and comprehensive survey. Epilepsia 2012;53(Suppl 3):1-51
   PubMed Web of Science ®Google Scholar
• Tan RY, Neligan A, Shorvon SD. The uncommon causes of status epilepticus: a systematic review. Epilepsy Res 2010;91(2-3):111-22
   PubMedGoogle Scholar
• Trinka E, Hofler J, Zerbs A. Causes of status epilepticus. Epilepsia 2012;53(Suppl 4):127-38
   PubMedGoogle Scholar
• Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci 1997;17(19):7532-40
   PubMed Web of Science ®Google Scholar
• Grohn O, Sierra A, Immonen R, et al. Multimodal MRI assessment of damage and plasticity caused by status epilepticus in the rat brain. Epilepsia 2011;52(Suppl 8):57-60
   PubMedGoogle Scholar
• Maru E, Ura H. [GABA(A) receptor trafficking and epilepsy]. Nihon Rinsho 2014;72(5):790-5
   PubMedGoogle Scholar
• Rotheneichner P, Marschallinger J, Couillard-Despres S, Aigner L. Neurogenesis and neuronal regeneration in status epilepticus. Epilepsia 2013;54(Suppl 6):40-2
   PubMedGoogle Scholar
• Winkler MK, Chassidim Y, Lublinsky S, et al. Impaired neurovascular coupling to ictal epileptic activity and spreading depolarization in a patient with subarachnoid hemorrhage: possible link to blood-brain barrier dysfunction. Epilepsia 2012;53(Suppl 6):22-30
   PubMedGoogle Scholar
• Wasterlain CG, Chen JW. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia 2008;49(Suppl 9):63-73
   PubMedGoogle Scholar
• Avanzini G, Depaulis A, Tassinari A, de Curtis M. Do seizures and epileptic activity worsen epilepsy and deteriorate cognitive function? Epilepsia 2013;54(Suppl 8):14-21
   PubMedGoogle Scholar
• Grosenbaugh DK, Mott DD. Stiripentol in refractory status epilepticus. Epilepsia 2013;54(Suppl 6):103-5
   PubMedGoogle Scholar
• Silbergleit R, Lowenstein D, Durkalski V, Conwit R. RAMPART. (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. Epilepsia 2011;52(Suppl 8):45-7
   PubMedGoogle Scholar
• Novy J, Rossetti AO. Oral pregabalin as an add-on treatment for status epilepticus. Epilepsia 2010;51(10):2207-10
   PubMedGoogle Scholar
• Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005;76(4):534-9
   PubMed Web of Science ®Google Scholar
• Abend NS, Dlugos DJ. Treatment of refractory status epilepticus: literature review and a proposed protocol. Pediatr Neurol 2008;38(6):377-90
   PubMed Web of Science ®Google Scholar
• Hofler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia 2013;54(3):393-404
   PubMed Web of Science ®Google Scholar
• Janz D. Historical vignette: medical treatment of status epilepticus. Epilepsia 2013;54(Suppl 6):3-10
   PubMed Web of Science ®Google Scholar
• Schmidt D, Schachter SC. Drug treatment of epilepsy in adults. BMJ 2014;348:g254
   PubMed Web of Science ®Google Scholar
• Henshall DC. MicroRNAs in the pathophysiology and treatment of status epilepticus. Front Mol Neurosci 2013;6:37
   PubMedGoogle Scholar
• Vespa PM, McArthur DL, Xu Y, et al. Nonconvulsive seizures after traumatic brain injury are associated with hippocampal atrophy. Neurol 2010;75(9):792-8
   PubMed Web of Science ®Google Scholar
• Vespa PM, Miller C, McArthur D, et al. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med 2007;35(12):2830-6
   PubMed Web of Science ®Google Scholar
• Csilla G, Vera J, Reka H, et al. [Status epilepticus and its treatment – update 2013]. Ideggyogy Sz 2013;66(11-12):372-82
   PubMedGoogle Scholar
• Freilich ER, Zelleke T, Gaillard WD. Identification and evaluation of the child in status epilepticus. Sem Pediatr Neurol 2010;17(3):144-9
   PubMedGoogle Scholar
• Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 2011;10(10):922-30
   PubMed Web of Science ®Google Scholar
• Seif-Eddeine H, Treiman DM. Problems and controversies in status epilepticus: a review and recommendations. Expert Rev Neurother 2011;11(12):1747-58
   PubMed Web of Science ®Google Scholar
• Varelas PN, Spanaki MV, Mirski MA. Status epilepticus: an update. Curr Neurol Neurosci Rep 2013;13(7):357
   PubMedGoogle Scholar
• Yamanouchi H. [Treatment of status epilepticus]. Nihon Rinsho 2014;72(5):895-901
   PubMedGoogle Scholar
• Sutter R, Kaplan PW, Ruegg S. Outcome predictors for status epilepticus – what really counts. Nat Rev Neurol 2013;9(9):525-34
   PubMed Web of Science ®Google Scholar
• Chen J, Cai F, Jiang L, et al. Levetiracetam efficacy in children with epilepsy with electrical status epilepticus in sleep. Epilepsy Behav 2015;44c:73-7
   Google Scholar
• Garcia-Perez E, Mahfooz K, Covita J, et al. Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking. Epilepsia 2015;56(4):535-45
   PubMedGoogle Scholar
• Isaacson JE, Choe DJ, Doherty MJ. Creatine phosphokinase elevation exacerbated by levetiracetam therapy. Epilepsy Behav Case Rep 2014;2:189-91
   PubMedGoogle Scholar
• Mazarati AM, Baldwin R, Klitgaard H, et al. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus. Epilepsy Res 2004;58(2-3):167-74
   PubMed Web of Science ®Google Scholar
• Navarro V, Dagron C, Demeret S, et al. A prehospital randomized trial in convulsive status epilepticus. Epilepsia 2011;52(Suppl 8):48-9
   PubMedGoogle Scholar
• Ramael S, Daoust A, Otoul C, et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 2006;47(7):1128-35
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Bromfield EB. Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 2006;8(3):651-4
   PubMed Web of Science ®Google Scholar
• Mastrangelo M, Celato A. Diagnostic work-up and therapeutic options in management of pediatric status epilepticus. World J Pediatr 2012;8(2):109-15
   PubMedGoogle Scholar
• Potter DE, Choudhury M. Ketamine: repurposing and redefining a multifaceted drug. Drug Discov Today 2014;19(12):1848-54
   PubMed Web of Science ®Google Scholar
• Martin BS, Kapur J. A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia 2008;49(2):248-55
   PubMedGoogle Scholar
• Pruss H, Holtkamp M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Res 2008;82(2-3):219-22
   PubMed Web of Science ®Google Scholar
• Esaian D, Joset D, Lazarovits C, et al. Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome. Ann Pharmacother 2013;47(11):1569-76
   PubMedGoogle Scholar
• Zeiler FA, Teitelbaum J, Gillman LM, West M. NMDA antagonists for refractory seizures. Neurocrit Care 2014;20(3):502-13
   PubMedGoogle Scholar
• US Food and Drug Administration. KETALAR-ketamine hydrochloride injection, 2013. Avaliable from www.fda.gov/safety/medwatch/safetyinformation/ucm299547.htm [Last accessed 10 December 2014]
   Google Scholar
• Inge A, Nasta F. New and old medications for croup and seizures in children. Oral dexamethasone and buccal midazolam may provide better treatment. Lakartidningen 2013;110(48):2163
   PubMedGoogle Scholar
• Fallah R, Yadegari Y, Behdad S, Akhavan Karbasi S. Melatonin and intravenous midazolam administered orally in drug induced sleep electroencephalography of children: randomized clinical trial of efficacy. Arch Iranian Med 2014;17(11):741-5
   PubMed Web of Science ®Google Scholar
• Brevoord JCD, Joosten KFM, Arts WFM, et al. Status Epilepticus: Clinical Analysis of a Treatment Protocol Based on Midazolam and Phenytoin. J Child Neurol 2005;20(6):476-81
   PubMedGoogle Scholar
• Gilbert DL, Gartside PS, Glauser TA. Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a meta-analysis. J Child Neurol 1999;14(9):602-9
   PubMedGoogle Scholar
• Hubert P, Parain D, Vallee L. Management of convulsive status epilepticus in infants and children. Rev Neurol 2009;165(4):390-7
   PubMedGoogle Scholar
• Singhi S, Murthy A, Singhi P, Jayashree M. Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus. J Child Neurol 2002;17(2):106-10
   PubMed Web of Science ®Google Scholar
• Saz EU, Karapinar B, Ozcetin M, et al. Convulsive status epilepticus in children: etiology, treatment protocol and outcome. Seizure 2011;20(2):115-18
   PubMedGoogle Scholar
• Tasker RC. Midazolam for refractory status epilepticus in children: higher dosing and more rapid and effective control. Intens Care Med 2006;32(12):1935-6
   PubMedGoogle Scholar
• Bankstahl JP, Loscher W. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus. Epilepsy Res 2008;82(1):70-85
   PubMedGoogle Scholar
• Hasson H, Kim M, Moshe SL. Effective treatments of prolonged status epilepticus in developing rats. Epilepsy Behav 2008;13(1):62-9
   PubMedGoogle Scholar
• Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339(12):792-8
   PubMed Web of Science ®Google Scholar
• Outin H. Generalized convulsive status epilepticus in emergency situations in and out of hospital. Presse Med 2009;38(12):1823-31
   PubMedGoogle Scholar
• Inoue Y, Ohtsuka Y, Oguni H, et al. Stiripentol open study in Japanese patients with Dravet syndrome. Epilepsia 2009;50(11):2362-8
   PubMed Web of Science ®Google Scholar
• Auvin S, Lecointe C, Dupuis N, et al. Stiripentol exhibits higher anticonvulsant properties in the immature than in the mature rat brain. Epilepsia 2013;54(12):2082-90
   PubMed Web of Science ®Google Scholar
• Grosenbaugh DK, Mott DD. Stiripentol is anticonvulsant by potentiating GABAergic transmission in a model of benzodiazepine-refractory status epilepticus. Neuropharmacology 2013;67:136-43
   PubMed Web of Science ®Google Scholar
• Da Settimo F, Taliani S, Trincavelli ML, et al. GABA A/Bz receptor subtypes as targets for selective drugs. Curr Med Chem 2007;14(25):2680-701
   PubMedGoogle Scholar
• Finne Lenoir X, Sindic C, van Pesch V, et al. Anti-N-methyl-D-aspartate receptor encephalitis with favorable outcome despite prolonged status epilepticus. Neurocrit Care 2013;18(1):89-92
   PubMedGoogle Scholar
• Davis R, Dalmau J. Autoimmunity, seizures, and status epilepticus. Epilepsia 2013;54(Suppl 6):46-9
   PubMedGoogle Scholar
• Hoftberger R, Titulaer MJ, Sabater L, et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 2013;81(17):1500-6
   PubMed Web of Science ®Google Scholar
• Lin JJ, Lin KL, Hsia SH, et al. Anti-N-methyl-D-aspartate receptor encephalitis in Taiwan – a comparison between children and adults. Pediatr Neurol 2014;50(6):574-80
   PubMedGoogle Scholar
• Gall CR, Jumma O, Mohanraj R. Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy. Seizure 2013;22(3):217-20
   PubMedGoogle Scholar
• Sutter R, Marsch S, Ruegg S. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study. CNS Drugs 2013;27(4):321-9
   PubMed Web of Science ®Google Scholar
• Kellinghaus C, Berning S, Immisch I, et al. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand 2011;123(2):137-41
   PubMed Web of Science ®Google Scholar
• Chen LL, Haneef Z, Dorsch A, et al. Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam. Seizure 2011;20(3):263-5
   PubMedGoogle Scholar
• Shiloh-Malawsky Y, Fan Z, Greenwood R, Tennison M. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide. Seizure 2011;20(7):586-8
   PubMedGoogle Scholar
• Fernandez EM, Franck AJ. Lacosamide for the treatment of refractory status epilepticus. Ann Pharmacother 2011;45(11):1445-9
   PubMedGoogle Scholar
• Rantsch K, Walter U, Wittstock M, et al. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Seizure 2011;20(7):529-32
   PubMedGoogle Scholar
• Mnatsakanyan L, Chung JM, Tsimerinov EI, Eliashiv DS. Intravenous Lacosamide in refractory nonconvulsive status epilepticus. Seizure 2012;21(3):198-201
   PubMedGoogle Scholar
• Hottinger A, Sutter R, Marsch S, Ruegg S. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study. CNS Drugs 2012;26(9):761-72
   PubMed Web of Science ®Google Scholar
• Reuber M, Evans J, Bamford JM. Topiramate in drug-resistant complex partial status epilepticus. Eur J Neurol 2002;9(1):111-12
   PubMedGoogle Scholar
• Towne AR, Garnett LK, Waterhouse EJ, et al. The use of topiramate in refractory status epilepticus. Neurology 2003;60(2):332-4
   PubMedGoogle Scholar
• Bensalem MK, Fakhoury TA. Topiramate and status epilepticus: report of three cases. Epilepsy Behav 2003;4(6):757-60
   PubMed Web of Science ®Google Scholar
• Kahriman M, Minecan D, Kutluay E, et al. Efficacy of topiramate in children with refractory status epilepticus. Epilepsia 2003;44(10):1353-6
   PubMed Web of Science ®Google Scholar
• Blumkin L, Lerman-Sagie T, Houri T, et al. Pediatric refractory partial status epilepticus responsive to topiramate. J Child Neurol 2005;20(3):239-41
   PubMed Web of Science ®Google Scholar
• Perry MS, Holt PJ, Sladky JT. Topiramate loading for refractory status epilepticus in children. Epilepsia 2006;47(6):1070-1
   PubMed Web of Science ®Google Scholar
• Kroll-Seger J, Portilla P, Dulac O, Chiron C. Topiramate in the treatment of highly refractory patients with Dravet syndrome. Neuropediatrics 2006;37(6):325-9
   PubMed Web of Science ®Google Scholar
• Soler B, Godoy J, Mellado Talesnik P. [Treatment of refractory status epilepticus with topiramate. Report of three cases]. Rev Med Chile 2009;137(7):936-9
   PubMedGoogle Scholar
• Bragatti JA, Torres CM, Netto CB, et al. Topiramate is effective for status epilepticus and seizure control in neuraminidase deficiency. Arq neuropsiquiatr 2011;69(3):565-6
   PubMed Web of Science ®Google Scholar
• Akyildiz BN, Kumandas S. Treatment of pediatric refractory status epilepticus with topiramate. Childs Nerv Syst 2011;27(9):1425-30
   PubMed Web of Science ®Google Scholar
• Stojanova V, Rossetti AO. Oral topiramate as an add-on treatment for refractory status epilepticus. Acta Neurol Scand 2012;125(2):e7-e11
   Google Scholar
• Synowiec AS, Yandora KA, Yenugadhati V, et al. The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center. Epilepsy Res 2012;98(2-3):232-7
   PubMedGoogle Scholar
• Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17(1):3-23
   PubMed Web of Science ®Google Scholar
• Zamponi N, Rychlicki F, Corpaci L, et al. Vagus nerve stimulation (VNS) is effective in treating catastrophic 1 epilepsy in very young children. Neurosurg Rev 2008;31(3):291-7
   PubMedGoogle Scholar
• Shahwan A, Bailey C, Maxiner W, Harvey AS. Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reduction. Epilepsia 2009;50(5):1220-8
   PubMed Web of Science ®Google Scholar
• Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010;51(10):2033-7
   PubMed Web of Science ®Google Scholar
• Nam SH, Lee BL, Lee CG, et al. The role of ketogenic diet in the treatment of refractory status epilepticus. Epilepsia 2011;52(11):e181-4
   Google Scholar
• Corry JJ, Dhar R, Murphy T, Diringer MN. Hypothermia for refractory status epilepticus. Neurocrit Care 2008;9(2):189-97
   PubMed Web of Science ®Google Scholar
• Orlowski JP, Erenberg G, Lueders H, Cruse RP. Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med 1984;12(4):367-72
   PubMedGoogle Scholar
• Kamel H, Cornes SB, Hegde M, et al. Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocrit Care 2010;12(2):204-10
   PubMed Web of Science ®Google Scholar
• Rotenberg A, Muller P, Birnbaum D, et al. Seizure suppression by EEG-guided repetitive transcranial magnetic stimulation in the rat. Clin Neurophysiol 2008;119(12):2697-702
   PubMedGoogle Scholar
• Loddenkemper T, Cosmo G, Kotagal P, et al. Epilepsy surgery in children with electrical status epilepticus in sleep. Neurosurgery 2009;64(2):328-37; discussion 37
   PubMedGoogle Scholar
• Alexopoulos A, Lachhwani DK, Gupta A, et al. Resective surgery to treat refractory status epilepticus in children with focal epileptogenesis. Neurology 2005;64(3):567-70
   PubMedGoogle Scholar
• Ng YT, Kerrigan JF, Rekate HL. Neurosurgical treatment of status epilepticus. J Neurosurg 2006;105(5 Suppl):378-81
   PubMedGoogle Scholar
• Ma X, Liporace J, O’Connor MJ, Sperling MR. Neurosurgical treatment of medically intractable status epilepticus. Epilepsy Res 2001;46(1):33-8
   PubMedGoogle Scholar
• Rogawski MA, Loya CM, Reddy K, et al. Neuroactive steroids for the treatment of status epilepticus. Epilepsia 2013;54(Suppl 6):93-8
   PubMed Web of Science ®Google Scholar
• Tawfik MK. Coenzyme Q10 enhances the anticonvulsant effect of phenytoin in pilocarpine-induced seizures in rats and ameliorates phenytoin-induced cognitive impairment and oxidative stress. Epilepsy Behav 2011;22(4):671-7
   PubMedGoogle Scholar
• Reddy K, Reife R, Cole AJ. SGE-102: a novel therapy for refractory status epilepticus. Epilepsia 2013;54(Suppl 6):81-3
   PubMedGoogle Scholar
• Yis U, Topcu Y, Ozbal S, et al. Caffeic acid phenethyl ester prevents apoptotic cell death in the developing rat brain after pentylenetetrazole-induced status epilepticus. Epilepsy Behav 2013;29(2):275-80
   PubMedGoogle Scholar
• Etsten B, Li TH. Hemodynamic changes during thiopental anesthesia in humans: cardiac output, stroke volume, total peripheral resistance, and intrathoracic blood volume. J Clin Invest 1955;34(3):500-10
   PubMedGoogle Scholar
• Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med 2009;37(12):3024-30
   PubMedGoogle Scholar
• Parviainen I, Kalviainen R, Ruokonen E. Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons. Neurol Res 2007;29(7):667-71
   PubMed Web of Science ®Google Scholar
• Prabhakar H, Bindra A, Singh GP, Kalaivani M. Propofol versus thiopental sodium for the treatment of refractory status epilepticus. Cochrane Database Syst Rev 2012;8:Cd009202
   Google Scholar
• Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002;43(2):146-53
   PubMed Web of Science ®Google Scholar
• Marchi NA, Novy J, Faouzi M, et al. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med 2015;43(5):1003-9
   PubMed Web of Science ®Google Scholar
• Kowalski RG, Ziai WC, Rees RN, et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 2012;40(9):2677-84
   PubMed Web of Science ®Google Scholar
• Sutter R, Marsch S, Fuhr P, et al. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014;82(8):656-64
   PubMed Web of Science ®Google Scholar
• Sutter R, Tschudin-Sutter S, Grize L, et al. Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study. Epilepsia 2012;53(9):1489-97
   PubMedGoogle Scholar
• Buzsaki G. Two-stage model of memory trace formation: a role for "noisy" brain states. Neuroscience 1989;31(3):551-70
   PubMed Web of Science ®Google Scholar
• Kroeger D, Amzica F. Hypersensitivity of the anesthesia-induced comatose brain. J Neurosci 2007;27(39):10597-607
   PubMedGoogle Scholar
• Steriade M, Amzica F, Contreras D. Cortical and thalamic cellular correlates of electroencephalographic burst-suppression. Electroencephalogr Clin Neurophysiol 1994;90(1):1-16
   PubMedGoogle Scholar
• Amzica F, Kroeger D. Cellular mechanisms underlying EEG waveforms during coma. Epilepsia 2011;52(Suppl 8):25-7
   PubMed Web of Science ®Google Scholar